Cros Carmellose Sodium

5000 USD ($)

Get a Price/Quote

Product Details:

Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Cros Carmellose Sodium Price And Quantity

Price 5000 USD ($)

Cros Carmellose Sodium Trade Information

Payment Terms Letter of Credit at Sight (Sight L/C) Telegraphic Transfer (T/T)
Supply Ability 5 Ton Per Month
Delivery Time 3 Week
Sample Available Yes
Sample Policy Within a certain price range free samples are available
Packaging Details Fiber drum ,Plastic, Carboys & Barrels.
Main Export Market(s) Australia North America South America Eastern Europe Western Europe Middle East Africa Central America Asia

Product Description

The goodness, we have gained in the market is due to the Cros Carmellose Sodium that is a cross linked polymer of carboxymethyl cellulose sodium and is wide in demand for its excellent drug dissolution and disintegration characteristics. The offered sodium is a vital source to improve bio availability of formulation. It is processed using top-notch quality basic chemicals under the direction of sourced pharmacists at vendors' end. Furthermore, proposed sodium is also checked on defined quality parameters to ensure its purity and effectiveness. Available in several packaging options to meet exact needs of clients, this Cros Carmellose Sodium can be availed from us at market leading prices.

Features:Deta

Purity
Precise composition
Precise pH value
Longer shelf life

Application:

It is used in oral pharmaceutical formulations as a disintegrant for Capsules, Tablets and Granules.
In tablet formulations, it may be used in both direct-compression and wet granulation processes.
When used in wet granulations, the cros carmellose sodium is best added in both the wet and dry stages of the process (intra- and extra granularly) so that the wicking and swelling ability of the disintegrant is best utilized.

Concentrations of up to 5% w/w of cros carmellose sodium may be used as a tablet disintegrant although normally 2% w/w is used in tablets prepared by direct compression and 3% w/w in tablets prepared by a wet-granulation process.